Stocks Health care BLFS
NASDAQ · Health careBiolife Solutions Inc (BLFS)
Biolife Solutions Inc brought in $106.7M of revenue over the twelve months to June 30, 2026, up 30.1% from a year earlier. Net income was $58M, a net margin of 54.3%. Operating cash flow minus capital spending left $10.6M of free cash flow in fiscal 2025. At June 30, 2026 it held $24M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
Key facts about Biolife Solutions Inc
- Net worth
- Biolife Solutions Inc has a market value (market cap) of $1.9B at the latest share price, and shareholders' equity of $420M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $96.2M (+28.9% year on year), with a net loss of $4.6M. Over the 12 months to June 30, 2026: revenue $106.7M, net income $58M.
- Cash flow
- In fiscal 2025 operations brought in $20.1M of cash; after $9.5M of capital spending, free cash flow was $10.6M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 6, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Biolife Solutions Inc's next report was expected around November 5, 2026 and is not on file with the SEC yet.
What Biolife Solutions Inc does
Biolife Solutions Inc is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker BLFS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $96.2M | -$4.6M | -$0.10 | $10.6M |
| 2024 | $74.6M | -$20.2M | -$0.44 | $5.2M |
| 2023 | $68M | -$68M | -$1.55 | -$18.9M |
| 2022 | $76.2M | -$139.8M | -$3.25 | -$18.9M |
| 2021 | $119.2M | -$8.9M | -$0.23 | -$13M |
| 2020 | $48.1M | $2M | -$0.06 | $4.7M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where BLFS ranks in Health care
Latest SEC filings
What Biolife Solutions Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 27, 2026Passive stake changed SCHEDULE 13G/A
- October 16, 2026Deregistration 15-12G
- October 6, 2026Form S-8 POS filing S-8 POS
- October 6, 2026Form S-8 POS filing S-8 POS
- October 6, 2026Form S-8 POS filing S-8 POS
- October 6, 2026Form POS AM filing POS AM
- October 6, 2026Form POS AM filing POS AM
- October 6, 2026Delisting notice 25-NSE
- October 6, 2026Change in control8-KRepligen Corporation completed its acquisition of BioLife Solutions on October 6, 2026.
- September 30, 2026Additional proxy material DEFA14A
What is BLFS worth? A DCF from its reported cash flow
Insider trades
What the people running Biolife Solutions Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 30 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 6, 2026 | Berard ToddChief Marketing Officer | Received as pay | 38,198 | - |
| October 6, 2026 | Berard ToddChief Marketing Officer | Received as pay | 40,192 | - |
| October 6, 2026 | Berard ToddChief Marketing Officer | Shares withheld for tax | 46,170 | $1.8M |
| October 6, 2026 | Berard ToddChief Marketing Officer | Other change | 194,786 | - |
| October 6, 2026 | Mathew Aby J.EVP & Chief Scientific Officer | Received as pay | 45,838 | - |
| October 6, 2026 | Mathew Aby J.EVP & Chief Scientific Officer | Received as pay | 40,192 | - |
| October 6, 2026 | Mathew Aby J.EVP & Chief Scientific Officer | Shares withheld for tax | 70,000 | $2.7M |
| October 6, 2026 | Mathew Aby J.EVP & Chief Scientific Officer | Other change | 404,608 | - |
Who owns BLFS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| BlackRock, Inc.13G, passive | 13.4% | October 27, 2026 |
| Casdin Capital, LLC13G, passive with 3 related filers | 9.7% | June 4, 2026 |
| T. Rowe Price Investment Management, Inc.13G, passive | 7.5% | September 8, 2026 |
| Glazer Capital, LLC13G, passive with 1 related filers | 5.49% | September 24, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 216 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 6,375,545 | +273,780 |
| Casdin Capital, LLC | 4,655,000 | -1,302,165 |
| Invesco Ltd. | 2,240,423 | -108,109 |
| Vanguard Capital Management LLC | 1,964,084 | +46,376 |
| State Street Corp | 1,655,927 | +78,851 |
| Geode Capital Management, LLC | 1,086,865 | +114,938 |
| Massachusetts Financial Services Co | 1,079,270 | -117,987 |
| Fred Alger Management, LLC | 1,077,577 | -2,358 |
| Dimensional Fund Advisors LP | 1,046,252 | +10,495 |
| Fmr LLC | 993,106 | -477,146 |
| Bank of America Corp | 950,159 | +46,056 |
| Vanguard Portfolio Management LLC | 913,226 | +48,188 |
| Royal Bank of Canada | 890,908 | +5,610 |
| UBS Group AG | 832,143 | +566,165 |
| Stephens Investment Management Group LLC | 708,666 | +35,537 |
| Millennium Management LLC | 625,658 | new |
| Royce & Associates LP | 623,875 | +39,864 |
| Geneva Capital Management LLC | 582,141 | -157,662 |
| Cramer Rosenthal McGlynn LLC | 575,792 | -57,020 |
| Next Century Growth Investors LLC | 558,829 | +196,889 |
Insiders
4 insiders reported holding 5,005,487 shares in total, about $193.3M at the last price.
| Holder | Shares |
|---|---|
| Casdin Partners Master Fund, L.P.10% owner | 4,757,1654,757,165 held indirectly |
| Foster Karen A.Chief Quality and Operations | 108,758 |
| Aebersold SarahChief Human Resources Officer | 92,429 |
| Werner SeanChief Technology Officer | 47,135 |
Questions about BLFS
What does Biolife Solutions Inc do?
Biolife Solutions Inc is a company in the Health care sector, listed on NASDAQ as BLFS. Its shares trade on NASDAQ under the ticker BLFS.
What is Biolife Solutions Inc's net worth?
Biolife Solutions Inc has a market value (market cap) of $1.9B at the latest share price, and shareholders' equity of $420M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Biolife Solutions Inc profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $58M on revenue of $106.7M, a net margin of 54.3%.
How much revenue does Biolife Solutions Inc make?
Over the twelve months to June 30, 2026 Biolife Solutions Inc reported revenue of $106.7M. That is 30.1% more than a year earlier.
When did Biolife Solutions Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from October 27, 2026.
When is Biolife Solutions Inc's next earnings report?
Biolife Solutions Inc's next report was expected around November 5, 2026 and is not on file with the SEC yet.
Similar companies
Compare BLFS with
Follow BLFS
Get an email when Biolife Solutions Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Biolife Solutions Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.